Literature DB >> 6501128

A simple method for the identification of aminoglycoside-modifying enzymes.

J A van de Klundert, J S Vliegenthart, E van Doorn, G P Bongaerts, L Molendijk, R P Mouton.   

Abstract

In order to study the correlation between the presence of aminoglycoside-modifying enzymes in bacteria and the susceptibility of these bacteria to aminoglycosides, 133 resistant strains were collected, representing the most frequently occurring modifying enzymes in clinical isolates today. Enzymes in these resistant strains were identified by the determination of substrate profiles for eight different aminoglycosides in vitro. Thirteen different enzymes or combinations of enzymes appeared to be present in this collection, whereas in seven cases the resistance appeared to be non-enzyme-mediated. The enzyme activities were not reflected in the bacterial susceptibility data for each antibiotic. Cluster analysis of the combined sensitivity data, with biochemical enzyme analysis as a guideline, proved to be unsatisfactory for the identification of aminoglycoside-modifying enzymes in clinical isolates. Much better results were obtained with a stepwise determination scheme. This method relies upon inhibition zone diameters around commercially available sensitivity discs for six aminoglycoside antibiotics. These zone diameters are compared with empirically established critical values, which are characteristic of an enzyme or group of enzymes. By this procedure proper identification of the enzyme(s) proved to be possible in 84% of the 133 resistant strains. For the evaluation of the method 100 consecutively isolated aminoglycoside resistant clinical isolates were analysed by means of the stepwise scheme and the biochemical method. Results were identical for 97 of the 100 strains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501128     DOI: 10.1093/jac/14.4.339

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates.

Authors:  K J Shaw; R S Hare; F J Sabatelli; M Rizzo; C A Cramer; L Naples; S Kocsi; H Munayyer; P Mann; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics.

Authors:  J G den Hollander; J W Mouton; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Nucleotide sequence of the aacC2 gene, a gentamicin resistance determinant involved in a hospital epidemic of multiply resistant members of the family Enterobacteriaceae.

Authors:  J S Vliegenthart; P A Ketelaar-van Gaalen; J A van de Klundert
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Bacterial resistance after in vitro exposure to amikacin and netilmicin.

Authors:  J A van de Klundert; J S Vliegenthart; R P Mouton
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

5.  Effect of aminoglycoside concentration on reaction rates of aminoglycoside-modifying enzymes.

Authors:  G P Bongaerts; J S Vliegenthart
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

6.  Construction of a gentamicin resistance gene probe for epidemiological studies.

Authors:  D J Groot Obbink; L J Ritchie; F H Cameron; J S Mattick; V P Ackerman
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

7.  Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials.

Authors:  L J Piddock; J M Diver; R Wise
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

8.  In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance.

Authors: 
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

9.  Molecular epidemiology of two genes encoding 3-N-aminoglycoside acetyltransferases AAC(3)I and AAC(3)II among gram-negative bacteria from a Spanish hospital.

Authors:  M Alvarez; M C Mendoza
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

10.  Expression of the Pseudomonas aeruginosa gentamicin resistance gene aacC3 in Escherichia coli.

Authors:  R A van Boxtel; J A van de Klundert
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.